New combo therapy aims to tame tough blood cancer
NCT ID NCT05090566
First seen Nov 01, 2025 · Last updated Apr 17, 2026 · Updated 19 times
Summary
This study is testing a new drug called elranatamab, given alongside other cancer treatments, for people with multiple myeloma that has come back or stopped responding to standard therapies. The main goals are to find a safe and effective dose and to see if this combination can help control the cancer. It is for people who have already tried at least three other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
Calgary, Alberta, T2N 5G2, Canada
-
Banner Gateway Medical Center
Gilbert, Arizona, 85234, United States
-
Banner Gateway Medical Pavilion
Gilbert, Arizona, 85234, United States
-
Banner Health d.b.a. Banner MD Anderson Cancer Center
Phoenix, Arizona, 85012, United States
-
Banner MD Anderson Cancer Center
Gilbert, Arizona, 85234, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Beverly Hills Cancer Center
Beverly Hills, California, 90211, United States
-
Cedars Sinai Medical Center
Los Angeles, California, 90048, United States
-
Cedars Sinai Medical Center Oncology IDS Pharmacy Attn:Suwicha Limvorasak ,PharmaD
Los Angeles, California, 90048, United States
-
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI)
Los Angeles, California, 90048, United States
-
Cedars-Sinai Tarzana
Tarzana, California, 91356, United States
-
Clinical Research Advisors
Encino, California, 91316, United States
-
Clinical Research Advisors
Los Angeles, California, 90020, United States
-
Clinical Research Advisors
Los Angeles, California, 90048, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
OIDS, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, 21231, United States
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
-
Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida, 33146, United States
-
Sylvester Comprehensive Cancer Center- Deerfield Beach
Deerfield Beach, Florida, 33442, United States
-
The Johns Hopkins University School of Medicine
Baltimore, Maryland, 21205, United States
-
The Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
-
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Also Imaging Facility)
Baltimore, Maryland, 21231, United States
-
UHealth Tower
Miami, Florida, 33136, United States
-
University of Miami
Coral Gables, Florida, 33146, United States
Conditions
Explore the condition pages connected to this study.